EMCDDA home page | www.emcdda.europa.eu

2022 European Drug Report

What do the latest data tell us about trends in drug use and the market? What hazardous new drugs are emerging? What substances are posing the greatest health threats? Find out the answer to all of these questions, and more, in the European Drug Report 2022: Trends and Developments.

European Drug Report 2022

Spotlight

EU and Ukrainian flags side by side

EU solidarity with Ukraine

Lisbon Addictions 2022: progamme outline now available!

shows a close-up of a smartphone with someone selecting options on screen

Monitoring drug use in the digital age: studies in web surveys

EU Drug Markets: Cocaine

European Responses Guide

gavel and scales

Penalties for drug law offences in Europe at a glance

Wastewater and drugs: a European multi.city study. Animated map of Europe with coloured bubbles over maps.

Wastewater analysis and drugs — a study

EU Drug Markets: Methamphetamiine

Computer simulation of a virus

Elimination barometer on viral hepatitis among people who inject drugs in Europe

A happy small boy and a girl lying on a skateboard with arms outstreched as though flying. They are on the road, there are no cars and the sun is shining.

Prevention toolkit: your one-stop shop for EMCDDA prevention materials

Latest news

photo of Alexis Goosdeel, Director of the EMCDDA, and Mr Tornike Cheishvili, Deputy Minister of the Ministry of justice of Georgia shaking hands and holding working arrangement

EMCDDA and Georgia sign new Working Arrangement in Tbilisi

06.09.2022

white cards with big black question mark on each card

International Overdose Awareness Day: EMCDDA answers key questions on drug-related deaths

31.08.2022

Justice and Home Affairs Agencies Network: CEPOL, EIGE, EMCDDA, EUAA, eu-LISA, Eurojust, Europol, FRA, Frontex. Grey EU countries map with lines connecting agencies with Ukraine in white background

EU Justice and Home Affairs agencies present concrete actions in support of Ukraine

23.08.2022

#WorldHepatitisDay — EMCDDA practical resources to help European countries beat viral hepatitis

28.07.2022

EMCDDA becomes official partner of COPOLAD III

21.07.2022

EU and Ukrainian flags side by side

Ukraine: EU Member States will need to prepare for possible increases in drug service demand

18.07.2022

white cards with big black question mark on each card

FAQ on drug overdose deaths in Europe

Global Cannabis Cultivation Research Consortium: a transnational online survey of cannabis growers

European Web Survey on Drugs 2021: Ukraine

European Web Survey on Drugs 2021: Georgia

European Web Survey on Drugs 2021: Lebanon

Cover of the trendspotter briefing on Ukraine

EMCDDA trendspotter briefing: Ukraine

Cover of the EU4MD briefing on prevention mapping

Mapping prevention systems in the European Neighbourhood Policy area

hand holding mobile phone replying to survey with other hand

Monitoring drug use in the digital age: studies in web surveys

Cover of the foresight toolkit guide

How to run a trends workshop: An EMCDDA foresight toolkit for the drugs field

Man holding a mobile phone in his hand

Spotlight on… e-health interventions

All publications

European Drug Report 2022: Trends and Developments

EU Drug Markets: In-depth analysis

Cover for theof health and social responses

European Responses Guide

cover of Prison and drugs in Europe: current and future challenges insights report

Prison and drugs in Europe

Wastewater POD's cover

Wastewater analysis and drugs — a European study

European Web Survey on Drugs 2021: EU countries

Publication cover

European Prevention Curriculum handbook

An analysis of drugs in used syringes from sentinel European cities

Medical use of cannabis and cannabinoids

All publications

Events

ISAM VALLETTA 2022 World Congress

04 Oct 2022 to 07 Oct 2022

Hybrid

Conference

Expert meeting on drug-related infectious diseases (DRID) 2021

06 Oct 2022 to 07 Oct 2022

Hybrid

EMCDDA expert meeting

28th MedNET Plenary Meeting

18 Oct 2022 to 19 Oct 2022

Nicosia, Cyprus

EU meeting

INHSU 2022

19 Oct 2022 to 21 Oct 2022

Hybrid (Glasgow and online)

Conference

Videos

video cover — shows a doctor wearing blue gloves about to perform an autopsy

Drug-related deaths: why data matter to save lives

Futuristic image with the EMCDDA webinar title

EMCDDA webinar: Preparing for the future — applying a foresight approach in the drugs field

EMCDDA webinar: Drug consumption rooms in Europe

EMCDDA webinar, Wednesday 25 May 2022, 13.00-14.30 CET (Brussels): Knowing youth - digital platforms for decision making (ESPAD and beyond)

EMCDDA webinar: Knowing youth — digital platforms for decision making (ESPAD and beyond)

EMCDDA webinar: workplaces and drugs, issues and challenges for the future, 28 April 2022 12.00-13-30 CET

EMCDDA webinar: Workplaces and drugs – issues and challenges for the future

photo of hands rolling a cannabis cigarette. Women and Drugs in Europe: why gender matters

EMCDDA webinar: Women and drugs in Europe — why gender matters

Data visualisations

Location of drug consumption facilities in Europe, November 2019. The map shows a concentration of facilities in Belgium, the Netherlands, Germany, Switzerland and parts of Spain

Infographic. Location and number of drug consumption facilities throughout Europe

Some key cannabis prevalance use data for young adults in Europe. Less than 20% have used cannabis in the last year. There are wide variations between countries, from 2% to over 20%. More men report using than women. Frequency of use varies widely.

Cannabis use in the last year in Europe – young adults (15-34)

While last year cocaine use among young people is low, in many countries in Europe it is close to 3%.

Infographic: cocaine use in the last year in Europe – young adults (15-34)

Graphic shows a series of pie charts for cannabis, cocaine, MDMA and amphetamines, showing drug prevalance rates in the EU. Cannabis is the most used drug with 7.7% of adults having used it in the last year. Last year use for cocaine is 1.2%, MDMA is 0.9%

At a glance — estimates of drug use in the European Union (updated June 2022)

Main behavioural techniques used in prevention interventions in high-risk neighbourhoods: evidence of effectiveness, 2019

Availability of awareness-raising responses in the workplace in Europe ranges from Finland (58.3%) to Estonia (20.9%) with an EU27 average at 36.2%.

Availability of awareness-raising responses in the workplace to prevent substance use (e.g. smoking, alcohol or drugs)

Interventions in high-risk neighbourhoods: provision in European countries, 2019

Infographic: Has the COVID-19 pandemic had any impact on your drug use?

Countries in the west of Europe are more likely to provide take-home naloxone than in the east of Europe

Infographic. Availability of take-home naloxone programmes in Europe

Explore emcdda.europa.eu

Loading